Entera Bio (ENTX) Shares Outstanding (Entity) (2017 - 2026)

Entera Bio (ENTX) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 254.16 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 147.69 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 200.18 Mn
10 Entera Bio 186.78 Mn 182.64 Mn - 46.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 46.62 Mn
Dec 31, 2025 149,700.00
Sep 30, 2025 45.66 Mn
Jun 30, 2025 45.45 Mn
Mar 31, 2025 45.42 Mn
Dec 31, 2024 38.84 Mn
Sep 30, 2024 36.51 Mn
Jun 30, 2024 36.31 Mn
Mar 31, 2024 35.53 Mn
Dec 31, 2023 29.01 Mn
Sep 30, 2023 28.81 Mn
Jun 30, 2023 28.81 Mn
Mar 31, 2023 28.81 Mn
Dec 31, 2022 28.81 Mn
Sep 30, 2022 28.81 Mn
Jun 30, 2022 28.81 Mn
Mar 31, 2022 28.80 Mn
Dec 31, 2021 28.80 Mn
Sep 30, 2021 28.78 Mn
Jun 30, 2021 28.29 Mn